These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13908452)

  • 1. Studies of delayed-action medication. I. Meprobamate administered as compressed tablets and as two delayed-action capsules.
    HOLLISTER LE
    N Engl J Med; 1962 Feb; 266():281-3. PubMed ID: 13908452
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid near IR spectrophotometric determination of meprobamate in pharmaceutical preparations.
    Zappala AF; Post A
    J Pharm Sci; 1977 Feb; 66(2):292-3. PubMed ID: 839437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DETERMINATION OF ISOMERIC PURITY OF DEXTROAMPHETAMINE IN TABLETS AND CAPSULES.
    BROCHMANN-HANSSEN E
    J Pharm Sci; 1964 Oct; 53():1287-8. PubMed ID: 14249470
    [No Abstract]   [Full Text] [Related]  

  • 4. SUSTAINED-ACTION AMPHETAMINE-MEPROBAMATE COMBINATION FOR THE TREATMENT OF OBESITY.
    BATTERMAN RC
    Curr Ther Res Clin Exp; 1964 Jul; 6():447-53. PubMed ID: 14203275
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and in vitro evaluation of slow release ketoprofen microcapsules formulated into tablets and capsules.
    el Khodairy KA; Eshra AG; Nada AH; Mortada SA
    J Microencapsul; 1992; 9(3):365-73. PubMed ID: 1403487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution behavior of commercial tablets extemporaneously converted to capsules.
    Shah PT; Moore WE
    J Pharm Sci; 1970 Jul; 59(7):1034-6. PubMed ID: 5428077
    [No Abstract]   [Full Text] [Related]  

  • 7. A disintegration test for evaluation of drug availability from tablets and capsules.
    Sandell E; Eriksson K; Mellström G
    Acta Pharm Suec; 1970 Nov; 7(5):559-66. PubMed ID: 5275191
    [No Abstract]   [Full Text] [Related]  

  • 8. [Method of manufacturing chronotabs-microtablets prepared for chronoactive capsules].
    Dallavalle V; Gal G
    Farmaco Prat; 1970 Jul; 25(7):440-5. PubMed ID: 5469693
    [No Abstract]   [Full Text] [Related]  

  • 9. The action of meprobamate on the release of ACTH.
    HOLBAN R; SAHLEANU V; DRAGOMIRESCU M
    Rev Sci Med; 1960; 5():169-72. PubMed ID: 13715216
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES OF PROLONGED-ACTION MEDICATION. III. PENTOBARBITAL SODIUM IN PROLONGED-ACTION FORM COMPARED WITH CONVENTIONAL CAPSULES: SERUM LEVELS OF DRUG AND CLINICAL EFFECTS FOLLOWING ACUTE DOSES.
    HOLLISTER LE; KANTER SL; CLYDE DJ
    Clin Pharmacol Ther; 1963; 4():612-8. PubMed ID: 14060202
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine.
    Hollister LE; Curry SH; Derr JE; Kanter SL
    Clin Pharmacol Ther; 1970; 11(1):49-59. PubMed ID: 5410895
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissolution of meprobamate from various tablet formulations.
    Hikal AH
    Pharmazie; 1983 Dec; 38(12):864-6. PubMed ID: 6669616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative pharmacokinetic study of 2 galenic forms of 5 mg trihexyphenidyl; tablets (Artane) and sustained-release capsules (Parkinane retard)].
    Devissaguet JP; Garbarg S; Prost M; Bogaievsky Y
    Therapie; 1984; 39(3):231-6. PubMed ID: 6463950
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research on the mode of action of meprobamate on the course of pregnancy in the rat].
    BERTRAND M
    C R Seances Soc Biol Fil; 1961; 155():514-6. PubMed ID: 13868511
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of isosorbide-5-mononitrate from delayed-action formulations].
    Taylor T; Major RM; Leaf FC; Cook SC; Chasseaud LF; Darragh A; Lambe RF
    Arzneimittelforschung; 1984; 34(11):1584-7. PubMed ID: 6543135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron absorption from 'Feospan' capsules and ferrous sulphate tablets B.P.
    Fitzsimons EJ; Thomson W; Jacobs A
    Br J Clin Pharmacol; 1984 Jan; 17(1):111-3. PubMed ID: 6691883
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and acute side-effects of nifedipine given as slow-release tablets or liquid-filled capsules.
    Saano V; Raatikainen O; Paronen P; Komulainen H
    Int J Clin Pharmacol Res; 1989; 9(4):247-54. PubMed ID: 2777428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crushing tablets or opening capsules: many uncertainties, some established dangers.
    Prescrire Int; 2014 Sep; 23(152):209-11, 213-4. PubMed ID: 25325120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of polyacrylate dispersions for nebulization of phenobarbital. 2. In vitro testing of tablets with phenobarbital polyacrylate microspheres].
    Traue J; Kala H
    Pharmazie; 1984 May; 39(5):331-3. PubMed ID: 6473494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.